top of page
a1_ultra_sharp.png

Agostston 2.0

12_highres_enhanced.png

Agostston 2.0

f03de68d-a943-47f4-8c52-928f6064e8a2.png

Agatston 2.0

A Next-Generation AI-Based Coronary Calcium Quantification Set to Improve risk Stratification among Individuals with Low Agatston Scores - Part 1

dac531_93bbc5f9f50d4545a890101ea925b4fa~mv2 (1).avif
36c2c551-50ea-4ece-aab3-0a773ed91153.png

Key Co-author Affiliations Quoted in This Release

Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

ISO LOGO_edited.png

Contact

contact@heartlung.ai

(310) 510-6004

Company

HeartLung Corporation

​

Mission

Resources

Knowledge Center

Privacy Policy

aicvd patent_edited_edited.jpg

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

Contact

contact@heartlung.ai

(310) 510-6004

Company

HeartLung Corporation

​

Mission

Resources

Knowledge Center
 

Privacy Policy

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page